reinfection case is not peer reviewed. Immunity means your body can fight it off quickly. It does not mean you have a magic shield. It is clear we are seeing a global immunity. We already have studies showing that everyone that got SARS-CoV-1 have T Cells that gave them immunity to SARS-CoV-2.
“ We then showed that SARS-recovered patients (n=23) still possess long-lasting memory T cells reactive to SARS-NP 17 years after the 2003 outbreak, which displayed robust cross-reactivity to SARS-CoV-2 NP. Surprisingly, we also frequently detected SARS-CoV-2 specific T cells in individuals with no history of SARS, COVID-19 or contact with SARS/COVID-19 patients (n=37) “
We do not know that every virus in the past we have built up some sort of immunity. Here are my main takeaways from the article and study.
SARS-CoV-1 from 2003 has shown to give T Cell immunity to SARS-CoV-2
betaCoronaviruses found in pets like dogs seem to help with immunity and that immunity could last a lifetime
That SARS-CoV-1 showed to only have 3 years of antibody protection but the T Cell protection is still observable 17 years later
That a vaccine may focus on T Cell instead of Antibodies
It is likely that SARS-CoV-2 will have other common features of SARS-CoV-1.
SARS-CoV-1 lasted 10 months and started in November of 2002 and vanished in July of 2003 globally.
If SARS-CoV-2 lasts 10 months and started in December of 2019 then we are looking at it ending in August of 2020
Also remember that the early testing was not very accurate. That person may have had the FLU or some other virus and are in fact not reinfected. If it was going to happen we would see it in large numbers
I have just read an article about people who got it again. Time will tell.
reinfection case is not peer reviewed. Immunity means your body can fight it off quickly. It does not mean you have a magic shield. It is clear we are seeing a global immunity. We already have studies showing that everyone that got SARS-CoV-1 have T Cells that gave them immunity to SARS-CoV-2.
“ We then showed that SARS-recovered patients (n=23) still possess long-lasting memory T cells reactive to SARS-NP 17 years after the 2003 outbreak, which displayed robust cross-reactivity to SARS-CoV-2 NP. Surprisingly, we also frequently detected SARS-CoV-2 specific T cells in individuals with no history of SARS, COVID-19 or contact with SARS/COVID-19 patients (n=37) “
https://www.nature.com/articles/s41586-020-2550-z_reference.pdf
We do not know that every virus in the past we have built up some sort of immunity. Here are my main takeaways from the article and study.
SARS-CoV-1 from 2003 has shown to give T Cell immunity to SARS-CoV-2 betaCoronaviruses found in pets like dogs seem to help with immunity and that immunity could last a lifetime
That SARS-CoV-1 showed to only have 3 years of antibody protection but the T Cell protection is still observable 17 years later That a vaccine may focus on T Cell instead of Antibodies It is likely that SARS-CoV-2 will have other common features of SARS-CoV-1.
SARS-CoV-1 lasted 10 months and started in November of 2002 and vanished in July of 2003 globally.
If SARS-CoV-2 lasts 10 months and started in December of 2019 then we are looking at it ending in August of 2020
Also remember that the early testing was not very accurate. That person may have had the FLU or some other virus and are in fact not reinfected. If it was going to happen we would see it in large numbers